Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Short Interest Down 85.1% in June
by Jessica Moore · The Cerbat GemReckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) saw a significant decrease in short interest during the month of June. As of June 30th, there was short interest totaling 150,494 shares, a decrease of 85.1% from the June 15th total of 1,009,848 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 1,428,492 shares, the short-interest ratio is currently 0.1 days.
Analysts Set New Price Targets
A number of research firms recently issued reports on RBGLY. Morgan Stanley raised Reckitt Benckiser Group from an “equal weight” rating to an “overweight” rating in a report on Monday, March 16th. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Reckitt Benckiser Group in a research report on Tuesday, June 30th. Zacks Research upgraded shares of Reckitt Benckiser Group from a “strong sell” rating to a “hold” rating in a research report on Monday, June 15th. Finally, Kepler Capital Markets raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, April 17th. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy”.
View Our Latest Report on RBGLY
Reckitt Benckiser Group Stock Up 0.7%
Shares of RBGLY stock traded up $0.09 on Friday, reaching $13.56. 303,890 shares of the stock were exchanged, compared to its average volume of 715,378. Reckitt Benckiser Group has a one year low of $12.02 and a one year high of $17.80. The company has a current ratio of 0.85, a quick ratio of 0.63 and a debt-to-equity ratio of 0.98. The stock has a 50 day moving average price of $12.77 and a 200 day moving average price of $14.56.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.